🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Saiama N. Waqar

University of Washington

ORCID: 0000-0002-7069-5456

Also affiliated with Washington University in St. Louis, Jewish Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)”.

A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.09.013

N/A

2.3DataRank · unranked

79 citations

Mary W. Redman, Susanne M. Arnold, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +12 more

Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.07.024

N/A

0.326DataRank · unranked

5 citations

Xing Hua, Michael C. Wu, Khaled Tolba, Saiama N. Waqar, Konstantin H. Dragnev +10 more

Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance)/RTOG 0538.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8505

N/A

0DataRank · unranked

37 citations

Xiaofei F. Wang, Gregory A. Masters, Junheng Gao, Ritsuko Komaki, Charles Kuzma +8 more

NCI 9938: Phase I clinical trial of ATR inhibitor berzosertib (M6620, VX-970) in combination with irinotecan in patients with advanced solid tumors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3012

N/A

0DataRank · unranked

13 citations

Karen Kelly, Saiama N. Waqar, Elizabeth J. Davis, Geoffrey I. Shapiro, Patricia LoRusso +7 more

Comparison of quality of life in patients randomized to high-dose once daily (QD) thoracic radiotherapy (TRT) with standard twice daily (BID) TRT in limited stage small cell lung cancer (LS-SCLC) on CALGB 30610 (Alliance, Sub-study CALGB 70702).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8504

N/A

0DataRank · unranked

4 citations

Amylou C. Dueck, Briant Fruth, Andreas Rimner, Saiama N. Waqar, M. Mix +3 more

Representativeness of patients enrolled in the Lung Cancer Master Protocol (Lung-MAP).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6543

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Qian Lü, Katherine Minichiello, Roy S. Herbst, David R. Gandara +14 more

The effect of ctDNA tumor fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9035

N/A

0DataRank · unranked

0 citations

Mary W. Redman, David Kozono, Sam Callis, Hanna Tukachinsky, Khaled Tolba +14 more

Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): Alliance

Cancer(2024)10.1002/cncr.35663

N/A

0DataRank · unranked

3 citations

Briant Fruth, Andreas Rimner, Saiama N. Waqar, M. Mix, W. Jeffrey Petty +5 more

Factors associated with incomplete resection for large, locally invasive non-small cell lung cancer

Journal of Thoracic Disease(2024)10.21037/jtd-23-989

N/A

0DataRank · unranked

2 citations

Zhizhou Yang, Brendan T. Heiden, Pamela Samson, Daniel Morgensztern, Saiama N. Waqar +6 more

Molecular Tumor Boards: A Consensus Statement From the International Association for the Study of Lung Cancer

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.07.009

N/A

0DataRank · unranked

5 citations

Julia Rotow, Maria E. Arcila, M. Hatton, Lynette M. Sholl, Christian Rolfo +35 more

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

Clinical Lung Cancer(2025)10.1016/j.cllc.2025.09.009

N/A

0DataRank · unranked

0 citations

Leena Gandhi, Vignesh Ravichandran, Benjamin Besse, Julien Mazières, Geoffrey I. Shapiro +20 more

Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial

JCO Precision Oncology(2021)10.1200/po.20.00372

N/A

0DataRank · unranked

45 citations

Shivaani Kummar, Nancy Moore, Larry Rubinstein, Yingdong Zhao, P. Mickey Williams +20 more